Skip to main content
Ingrid Vanderelst Toronto Lawyer

Ingrid E. VanderElst, PhD *

Partner | Trademark Agent Fasken
The Life Sciences Industry is highly regulated.
Jurisdiction Ontario, 2000
Language(s) English, Italian
Office(s) Toronto
*practising through a professional corporation


Ingrid VanderElst is co-chair of the Ontario region’s Life Sciences group. Regularly assisting clients in the health products and related service industries, Ingrid advises on regulatory and intellectual property issues. Clients include pharmaceutical, natural health product, medical device, cosmetic and food manufacturers, as well as pharmacy and laboratory services providers and agri-business operators.

On the regulatory side, Ingrid has assisted clients with product licensing, establishment licensing, manufacturing requirements (including GMP compliance), packaging and labeling reviews, as well as advised on advertising, marketing and distribution, product recalls, drug pricing (including PMPRB compliance) and reimbursement issues, including formulary listing.  As regards intellectual property matters, she advises on licensing and transfer of patents and trademarks, patent and trademark prosecution, patent listing under the Patented Medicines (Notice of Compliance) Regulations and data protection, and provides support on the acquisition or disposition of technology assets and intellectual property portfolios.

A significant component of Ingrid’s practice relates to advising clients on privacy related to regulated health products and allied services industries. This includes providing guidance on health privacy issues associated with clinical trials, sponsored research and patient support programs, as well as privacy considerations that arise in connection with commercial operations of pharmacies, laboratories and other health services providers. Ingrid has assisted clients with drafting patient informed consents in the context of clinical trials and patient support programs, drafting privacy policies and consents for patient-facing websites, providing guidance concerning information transfers in connection with corporate transactions and dealing with privacy complaints and privacy breaches, including assessment of reporting obligations. Ingrid also provides advice concerning compliance with Canada’s anti-spam law for companies operating within the regulated health products and related services industries.

Ingrid hold a Ph.D. in genetics. Previous experience in the field includes the development of anti-metastatic chemotherapeutics and the study of gene regulation during oncogenesis.

Ingrid is a registered trade-mark agent.


Client Work

  • Anjac SAS acquires Apollo Healthcare Corp.,
  • Aphria and Tilray complete C$5 billion business combination to create largest global cannabis company,
  • Sterling Packers Limited closes its sale to Premium Brands Holdings Corporation,
  • McCain Foods Limited sells a majority stake in Wong Wing Foods,
  • Village Farms International Inc. Completes $28.75 Million Bought Deal Offering of Common Shares,
  • The Flowr Corporation completes a C$43.5 million equity financing,
  • Kraft Heinz Co’s C$1.62 billion sale of its Canadian natural cheese business to Parmalat SpA,
  • Aphria completes US$350 million offering of convertible senior notes,
  • Village Farms International completes C$22 million bought deal prospectus offering,

Career & Education


  • LLB Osgoode Hall Law School at York University
  • Ph. D., Genetics
  • MSc, Medical Genetics University of Toronto
  • BSc, gold medallist, Genetics University of Western Ontario

Community involvement

  • Committee member, Animal Care Committee, Toronto Centre for Phenogenomics, (2010-2012)

Memberships & Affiliations

  • Member, Orphan Drug Group, BIOTECanada
  • Member, SEB Task Force, BIOTECanada
  • Member, Canadian Bar Association, Biotechnology Committee
  • Member, American Bar Association, Health Law Section


Fasken Institute



Article Health Canada is cracking the whip on advertising violations Inside Internal Controls
Article Draft Update to Intellectual Property Enforcement Guidelines Competition Chronicle
Book Innovation Under Siege: Definition of Innovative Drug Narrowed for Purposes of Data Protection Life Sciences Bulletin

Speaking Engagements

Do’s and Don’ts of Buying and Selling your IP Assets location location Toronto
Orphan Drugs: Legal Perspectives Health Canada Regulatory Reforms Summit, Strategy Institute


    Receive email updates from our team